Personal profile
Research interests
Clinical trials in breast cancer especially in patients with triple negative disease, early-onset breast cancer, racial disparities.
Clinical interests
Medical Oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Foluso Ademuyiwa is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
Kong, T., Mabry, A., Highkin, M., Wang, A. Z., Hoog, J., Guo, Z., Gonzales-Gonzales, A., Thomas, S., Song, Y., Gao, F., Opyrchal, M., Peterson, L., Ademuyiwa, F., Margenthaler, J., Aft, R., Glover-Collins, K., Nehring, L., Tao, Y., Sanati, S. & Hagemann, I. S. & 14 others, , Dec 2026, In: Nature communications. 17, 1, 949.Research output: Contribution to journal › Article › peer-review
Open Access -
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial
Mishra, R., Ademuyiwa, F., Yang, Y., Herndon, J., Li, L., Street, C., Myers, N., Chen, I., Zhang, X., Hagemann, I. S., Gao, F., Miller, C. A., Sankpal, N. V., Guthridge, J. M., Carmody, M., Ma, C. X., Suresh, R., Fleming, T. P., Marlin, C. & Goedegebuure, S. P. & 1 others, , Apr 1 2026, In: Cancer immunology research. 14, 4, p. 543-558 16 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer
Ademuyiwa, F. O., Ma, C. X., Weilbaecher, K., Suresh, R., Peterson, L. L., Bose, R., Bagegni, N., Rigden, C. E., Frith, A., Clifton, K., Dustin, D., Cai, M., Xiong, L., Chen, S. & Davis, A. A., Jun 1 2025, In: Clinical Cancer Research. 31, 11, p. 2173-2182 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer
Tapiavala, S., Liu, Y., Roy, S., Hensing, W., Ademuyiwa, F. O. & Cyr, A. E., Nov 2025, In: Annals of Surgical Oncology. 32, 12, p. 8628-8635 8 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer
Podany, E. L., Foffano, L., Gerratana, L., Medford, A. J., Clifton, K., Tapiavala, S., Velimirovic, M., Lipsyc-Sharf, M., Reduzzi, C., Bubie, A., Putur, A., Ademuyiwa, F. O., Puglisi, F., Gradishar, W. J., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Feb 26 2025, In: JAMA Network Open. 8, 2, p. e2461899Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations